Promedica Becomes the Exclusive Distributor of the CareSens Air System: Officially Introduced at the EASD Congress in Vienna
We are pleased to announce that Promedica has been appointed the exclusive distributor of the CareSens Air system by i-SENS, Inc. for the Czech Republic. This innovative continuous glucose monitoring (CGM) system was recently unveiled at the international EASD Congress in Vienna, where the manufacturer presented its key benefits, features, and upcoming availability for both physicians and patients.
About i-SENS, Inc.
i-SENS, Inc. is a global company headquartered in South Korea, specializing in diagnostic technologies for diabetes care, particularly blood glucose monitoring systems and now CGM devices. Their CareSens Air system offers:
-
A 15-day sensor for continuous monitoring of glucose levels in interstitial fluid, transmitting data every 5 minutes.
-
An ultra-thin and lightweight sensor (approx. 35.2 × 19.2 × 5.0 mm, weighing only 4.5 g), designed for comfortable everyday wear.
-
Water resistance (IP48), allowing use while showering, bathing, and during daily activities.
-
The CareSens Air app and Sens365 platform, enabling trend tracking, alerts, data sharing, and advanced reporting for both patients and healthcare professionals.
Our Presence at the EASD Congress in Vienna
-
We had the opportunity to personally meet and greet many Czech physicians, sharing detailed information about CareSens Air.
-
We introduced the professional community to the upcoming launch of CGM in the Czech Republic, its technical features, and its advantages over current solutions.
-
We gathered valuable feedback from physicians—particularly highlighting accuracy, patient comfort, ease of use, and data-sharing capabilities as highly appreciated benefits.
What This Means for Patients and the Czech Healthcare System
For patients, CareSens Air promises greater flexibility and comfort in everyday diabetes management—without frequent finger pricks, with timely alerts for hypo- and hyperglycemia, clear trend reports, and seamless data sharing with healthcare providers.
For the healthcare system, the adoption of CGM has the potential to improve early detection of irregularities, support better glycemic stability, and reduce diabetes-related complications.
We extend our gratitude to all who contributed at the congress—manufacturers, physicians, and partners alike. We are excited to soon bring CareSens Air to Czech patients with diabetes.
Diabetology Division
